Top News: ArcelorMittal SA (ADR) (NYSE:MT), Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), Community West Bancshares (NASDAQ:CWBC), Hawaiian Holdings Inc. (NASDAQ:HA), BRF S.A. (NYSE:BRFS)

ArcelorMittal SA (ADR) (NYSE:MT) South Africa is seeking duties on steel imports from China as the continent’s largest producer tries to return to profitability after posting three straight years of losses. ArcelorMittal SA (ADR) (NYSE:MT) belongs to Basic Materials sector. Its net profit margin is -2.00% and weekly performance is -5.57%. On last trading day company shares ended up $12.37. ArcelorMittal SA (ADR) (NYSE:MT) distance … Continue reading Top News: ArcelorMittal SA (ADR) (NYSE:MT), Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), Community West Bancshares (NASDAQ:CWBC), Hawaiian Holdings Inc. (NASDAQ:HA), BRF S.A. (NYSE:BRFS)

Mark Doerr11/05

Morning Alert : Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), Campus Crest Communities, Inc. (NYSE:CCG), Worthington Industries, Inc. (NYSE:WOR), Facebook Inc (NASDAQ:FB), Google Inc (NASDAQ:GOOG)

Merrimack Pharmaceuticals (NASDAQ:MACK) SVP Edward J. Stewart unloaded 3,000 shares of the company’s stock on the open market in a transaction that occurred on Thursday, October 23rd. The shares were sold at an average price of $9.05, for a total transaction of $27,150.00. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) shares moved up 2.07% in last trading session and ended the day at $9.35. MACK return on assets … Continue reading Morning Alert : Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), Campus Crest Communities, Inc. (NYSE:CCG), Worthington Industries, Inc. (NYSE:WOR), Facebook Inc (NASDAQ:FB), Google Inc (NASDAQ:GOOG)

Kristen Barton10/29

Morning Watch List : Two Harbors Investment Corp. (NYSE:TWO), Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), Limoneira Company (NASDAQ:LMNR), ATRION Corp. (NASDAQ:ATRI), Ameriprise Financial, Inc. (NYSE:AMP),

Two Harbors Investment Corp (NYSE:TWO) declared a quarterly dividend on Tuesday, September 16th, Analyst Ratings.Net reports. Stockholders of record on Tuesday, September 30th will be given a dividend of 0.26 per share on Tuesday, October 21st. This represents a $1.04 dividend on an annualized basis and a yield of 10.25%. The ex-dividend date of this dividend is Friday, September 26th. Two Harbors Investment Corp. (NYSE:TWO) … Continue reading Morning Watch List : Two Harbors Investment Corp. (NYSE:TWO), Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), Limoneira Company (NASDAQ:LMNR), ATRION Corp. (NASDAQ:ATRI), Ameriprise Financial, Inc. (NYSE:AMP),

Kevin Long09/29

Don’t Miss: Merrimack Pharmaceuticals (NASDAQ:MACK), Acorda Therapeutics (NASDAQ:ACOR), USA Compression Partners, LP (NYSE:USAC), Halliburton Company (NYSE:HAL), Google Inc. (NASDAQ:GOOG)

On 4 AUG Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that the company will host its Second Quarter 2014 Investor Conference Call on Monday, August 11. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) belongs to Healthcare sector. Its weekly performance is 12.98%. On last trading day company shares ended up $6.53. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) distance from 50-day simple moving average (SMA50) is -5.40%. On 31 JULY Acorda Therapeutics, Inc. … Continue reading Don’t Miss: Merrimack Pharmaceuticals (NASDAQ:MACK), Acorda Therapeutics (NASDAQ:ACOR), USA Compression Partners, LP (NYSE:USAC), Halliburton Company (NYSE:HAL), Google Inc. (NASDAQ:GOOG)

Kevin Long08/11

Biotech Insider Buying: Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros (NASDAQ:OMER), Insys Therapeutics (NASDAQ:INSY), Agios Pharmaceuticals (NASDAQ:AGIO), BioTime (NYSEMKT:BTX)

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Director Gary L. Crocker bought 36,000 shares of the stock in a transaction dated Monday, June 23rd. The shares were purchased at an average price of $6.84 per share, with a total value of $246,240.00. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock performance was 3.91% in last session and finished the day at $7.44. Traded volume was 1.38million shares in the last session … Continue reading Biotech Insider Buying: Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros (NASDAQ:OMER), Insys Therapeutics (NASDAQ:INSY), Agios Pharmaceuticals (NASDAQ:AGIO), BioTime (NYSEMKT:BTX)

Ryan Holtz06/26

Small Cap Insider Buying: Hercules Offshore (NASDAQ:HERO), Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros Corporation (NASDAQ:OMER), Insys (NASDAQ:INSY), New Mountain Finance (NYSE:NMFC)

Hercules Offshore Inc (NASDAQ:HERO) Director Thomas R. Bates, Jr. purchased 20,000 shares of the stock on the open market in a transaction that occurred on Tuesday, June 24th. The stock was purchased at an average price of $3.93 per share, for a total transaction of $78,600.00. Following the completion of the transaction, the director now directly owns 280,000 shares in the company, valued at approximately … Continue reading Small Cap Insider Buying: Hercules Offshore (NASDAQ:HERO), Merrimack Pharmaceuticals (NASDAQ:MACK), Omeros Corporation (NASDAQ:OMER), Insys (NASDAQ:INSY), New Mountain Finance (NYSE:NMFC)

Kristen Barton06/26